KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Air Products & Chemicals (APD) Cash & Equivalents (2016 - 2025)

Air Products & Chemicals' Cash & Equivalents history spans 17 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents changed N/A year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, changed N/A, while the annual FY2024 figure was $3.0 billion, 84.27% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.0 billion at Air Products & Chemicals, down from $3.0 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $5.8 billion in Q1 2021 and bottomed at $1.0 billion in Q4 2025.
  • The 5-year median for Cash & Equivalents is $3.0 billion (2022), against an average of $3.1 billion.
  • The largest annual shift saw Cash & Equivalents soared 160.63% in 2021 before it plummeted 59.41% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $3.0 billion in 2021, then increased by 6.0% to $3.1 billion in 2022, then plummeted by 48.36% to $1.6 billion in 2023, then surged by 84.27% to $3.0 billion in 2024, then crashed by 65.55% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for APD's Cash & Equivalents are $1.0 billion (Q4 2025), $3.0 billion (Q3 2024), and $1.6 billion (Q3 2023).